text.skipToContent text.skipToNavigation

Therapeutic Drugs-Antibiotics (ANTIBIOTICS)

daps UKAS Logo
  • UKAS accredited proficiency testing scheme
  • The LGC Therapeutic Drugs Monitoring (TDM) proficiency testing scheme provides independent performance assessment for the routine quantification of a wide range of anti-epileptic and other therapeutic drugs.
  • Antibiotic drugs (these analytes are produced in collaboration with the UKNEQAS for antibiotics drugs)
  • TDM is a measurement of specific drug concentration levels at timed intervals in patients, usually through blood/serum samples, and is necessary where control of drug concentrations is required to achieve optimum treatment for the patient, or where there is a narrow range between the therapeutic and toxic levels.
  • The operation of the LGC TDM scheme is supported by an Advisory Group consisting of members of the professional bodies, scheme participants, and others experienced in the field. The scheme reports on the performance of U.K. participants (who have clinical responsibilities) to the National Quality Assurance Advisory Panels for Chemical Pathology.
  • Scheme operates from January to December

 

Round dates

Round

Despatch date

Reporting deadline

AT18407 Jan 201924 Jan 2019
AT18504 Feb 201921 Feb 2019
AT18604 Mar 201921 Mar 2019
AT18701 Apr 201918 Apr 2019
AT18807 May 201923 May 2019
AT18903 Jun 201920 Jun 2019
AT19001 Jul 201918 Jul 2019
AT19105 Aug 201922 Aug 2019
AT19202 Sep 201919 Sep 2019
AT19307 Oct 201924 Oct 2019
AT19404 Nov 201921 Nov 2019
AT19502 Dec 201919 Dec 2019

null

Portal

PT online reporting

null

PT certification & accreditation

null

Order PT now

null

Catalogues

Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.